Organon Quarterly Cash Flow Statement
NYSE: OGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Organon free cash flow
In the quarter ended Jun 30, 2026, Organon generated $107.0 million of operating cash flow and spent $42.0 million on capital expenditures. That left free cash flow of $65.0 million, a free-cash-flow margin of 4.2% of revenue. Free cash flow was down 64.1% from the prior year's $181.0 million.
Organon returned $6.0 million to shareholders through dividends, equal to 9% of free cash flow. Free cash flow covered dividend payments 10.8 times.
Summary generated from market data by MetaCap's automated system. Methodology
Organon cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 108.00M | 146.00M | -205.00M | 160.00M | 145.00M | 87.00M | 109.00M | 359.00M | 195.00M | 201.00M | 546.00M | 58.00M |
| Net Income growth (YoY) | -25.52% | +67.82% | -288.07% | -55.43% | -25.64% | -56.72% | -80.04% | +518.97% | -19.42% | +13.56% | +405.56% | -74.45% |
| Depreciation & Amortization | 34.00M | 39.00M | 46.00M | 40.00M | 36.00M | 34.00M | 34.00M | 34.00M | 32.00M | 32.00M | 32.00M | 32.00M |
| Stock-Based Compensation | 25.00M | 19.00M | 7.00M | 24.00M | 22.00M | 24.00M | 26.00M | 25.00M | 28.00M | 26.00M | 27.00M | 27.00M |
| Change in Working Capital | -72.00M | 53.00M | -35.00M | 17.00M | -83.00M | -192.00M | 295.00M | -202.00M | 83.00M | -182.00M | 179.00M | 116.00M |
| Operating Cash Flow | 107.00M | 225.00M | 141.00M | 264.00M | 220.00M | 75.00M | 390.00M | 141.00M | 332.00M | 76.00M | 397.00M | 261.00M |
| Capital Expenditures | -42.00M | -37.00M | -45.00M | -46.00M | -39.00M | -32.00M | -55.00M | -42.00M | -32.00M | -46.00M | -79.00M | -55.00M |
| Investing Cash Flow | -76.00M | 386.00M | -65.00M | -115.00M | -38.00M | -172.00M | -296.00M | -75.00M | -46.00M | -96.00M | -81.00M | -55.00M |
| Dividends Paid | -6.00M | -5.00M | -4.00M | -3.00M | -10.00M | -71.00M | -74.00M | -74.00M | -79.00M | -70.00M | -73.00M | -74.00M |
| Debt Issued | 0 | 0 | 325.00M | 300.00M | 340.00M | 90.00M | 150.00M | 0 | 1.04B | 0 | 0 | 0 |
| Debt Repaid | 0 | -32.00M | -507.00M | -372.00M | -541.00M | -93.00M | -152.00M | -2.00M | -1.04B | -2.00M | -2.00M | -2.00M |
| Financing Cash Flow | -12.00M | -38.00M | -187.00M | -76.00M | -223.00M | -75.00M | -82.00M | -78.00M | -134.00M | -74.00M | -77.00M | -78.00M |
| Net Change in Cash | 16.00M | 542.00M | -98.00M | 73.00M | 52.00M | -128.00M | -88.00M | 59.00M | 129.00M | -118.00M | 279.00M | 88.00M |
| Free Cash Flow | 65.00M | 188.00M | 96.00M | 218.00M | 181.00M | 43.00M | 335.00M | 99.00M | 300.00M | 30.00M | 318.00M | 206.00M |
This table shows 12 quarterly periods of Organon's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow OGN's reporting calendar. What is a cash flow statement?